Literature DB >> 22439076

The use of uterine artery doppler as a predictive tool for adverse gestational outcomes in pregnant patients with autoimmune and thrombophilic disease.

Roberta Capucci1, Elena Pivato, Simona Carboni, Elena Mossuto, Gabriella Castellino, Melissa Padovan, Marcello Govoni, Roberto Marci, Alfredo Patella.   

Abstract

OBJECTIVES: To verify whether Doppler velocimetry on the uterine arteries can be used to single out abnormal hemodynamic adjustments in the uteroplacental district and to prognose adverse gestational outcomes in pregnant women with autoimmune and trombophilic disease.
METHODS: The study included 67 patients divided into 3 groups selected by a developed pathology. Attention was given to the performance of the Resistance Index (RI) in Doppler velocimetry checks at 10th, 16th-18th, 21st and 28th weeks of gestation.
RESULTS: A significant correlation between Doppler values at week 21st and development of preeclampsia was observed (p <0.05) in the three patient groups. High Doppler values at the 21st week were found to be strongly associated (p <0.01) with preterm delivery. We also observed a significant correlation (p <0.05) between high Doppler values at week 21st and low weight at birth. Doppler was found to have a predictive power for gestational adverse outcomes already at week 16th.
CONCLUSION: RI values of more than 0.58 (taken as a cut-off) at 16/18th weeks allowed us to identify the category most at risk, if confirmed at 21 weeks.

Entities:  

Keywords:  Autoimmune diseases; Complications.; Doppler; Pregnancy

Year:  2011        PMID: 22439076      PMCID: PMC3279160     

Source DB:  PubMed          Journal:  J Prenat Med        ISSN: 1971-3282


  24 in total

Review 1.  How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview.

Authors:  P F Chien; N Arnott; A Gordon; P Owen; K S Khan
Journal:  BJOG       Date:  2000-02       Impact factor: 6.531

2.  Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis.

Authors:  F Carmona; J Font; M Azulay; M Creus; F Fábregues; R Cervera; B Puerto; J Balasch
Journal:  Am J Reprod Immunol       Date:  2001-10       Impact factor: 3.886

3.  Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population.

Authors:  O Gómez; J M Martínez; F Figueras; M Del Río; V Borobio; B Puerto; O Coll; V Cararach; J A Vanrell
Journal:  Ultrasound Obstet Gynecol       Date:  2005-10       Impact factor: 7.299

4.  Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies.

Authors:  S Campbell; J M Pearce; G Hackett; T Cohen-Overbeek; C Hernandez
Journal:  Obstet Gynecol       Date:  1986-11       Impact factor: 7.661

5.  Predictive value of uterine artery velocimetry at midgestation in low- and high-risk populations: a new perspective.

Authors:  L Caforio; A C Testa; C Mastromarino; B Carducci; M Ciampelli; D Mansueto; A Caruso
Journal:  Fetal Diagn Ther       Date:  1999 Jul-Aug       Impact factor: 2.587

6.  The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome.

Authors:  D Le Thi Huong; B Wechsler; D Vauthier-Brouzes; P Duhaut; N Costedoat; M R Andreu; G Lefebvre; J-C Piette
Journal:  Rheumatology (Oxford)       Date:  2005-10-25       Impact factor: 7.580

7.  Anticardiolipin antibodies in patients with recurrent pregnancy wastage: treatment and uterine blood flow.

Authors:  Z Blumenfeld; Z Weiner; M Lorber; P Sujov; I Thaler
Journal:  Obstet Gynecol       Date:  1991-10       Impact factor: 7.661

8.  Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome.

Authors:  A Caruso; S De Carolis; S Ferrazzani; G Valesini; L Caforio; S Mancuso
Journal:  Obstet Gynecol       Date:  1993-12       Impact factor: 7.661

Review 9.  Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy.

Authors:  A-S Bats; V Lejeune; E Cynober; E Safar; M Gonzales; J Milliez; B Carbonne
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2004-06-15       Impact factor: 2.435

10.  Second trimester uterine artery Doppler ultrasound as a screening test for adverse pregnancy outcome.

Authors:  R Axt-Fliedner
Journal:  Clin Exp Obstet Gynecol       Date:  2004       Impact factor: 0.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.